- PROCESSES FOR THE PREPARATION OF NIRAPARIB AND INTERMEDIATES THEREOF
-
The present invention relates to novel procedures and novel intermediates useful in the synthesis of Niraparib or any salt thereof.
- -
-
Paragraph 00208
(2019/03/05)
-
- Imidazole derivatives, its pharmaceutical composition and use thereof
-
Imidazolone compounds, pharmaceutically acceptable salts, solvates, polymorphs or prodrugs thereof are disclosed. Pharmaceutical compositions comprising above substances and uses for preventing and treating protein kinases related diseases, such as cancers, metabolic diseases, cardiovascular diseases and the like, are also disclosed.
- -
-
Paragraph 0544-0546
(2017/02/24)
-
- FAK AND FLT3 INHIBITORS
-
The use of a compound of the formula (I): (Formula (I)) in the preparation of a medicament for treating Acute Myeloid Leukemia or a disease ameliorated by the inhibition of Flt3, or Flt3 and FAK.
- -
-
-
- FAK INHIBITORS
-
A compound of the formula (I): where R1 or R2 is a cycle amine group and R5 is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.
- -
-
-
- Development of a fit-for-purpose large-scale synthesis of an oral PARP inhibitor
-
Compound (1) a poly(ADP-ribose)polymerase (PARP) inhibitor has been made by a fit-for-purpose large-scale synthesis using either a classical resolution or chiral chromatographic separation. The development and relative merits of each route are discussed,
- Wallace, Debra J.,Baxter, Carl A.,Brands, Karel J. M.,Bremeyer, Nadine,Brewer, Sarah E.,Desmond, Richard,Emerson, Khateeta M.,Foley, Jennifer,Fernandez, Paul,Hu, Weifeng,Keen, Stephen P.,Mullens, Peter,Muzzio, Daniel,Sajonz, Peter,Tan, Lushi,Wilson, Robert D.,Zhou, George,Zhou, Guoyue
-
p. 831 - 840
(2012/07/03)
-